Z. X. Xue
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Z. X. Xue has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
C. Z. Xu
Department of Gastroenterology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, 325000, Zhejiang Province, China
1 shared publicationL. L. Zhou
Department of Pathology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, 325000, Zhejiang Province, China
1 shared publicationL. M. Yu
Department of Gastroenterology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, 325000, Zhejiang Province, China
1 shared publicationY. S. Zhu
Department of Gastroenterology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, 325000, Zhejiang Province, China
1 shared publication- Zhenzhai Cai
International Science and Technology Cooperation Base for Tumor Translational Research of Zhejiang Province, Department of Gastrointestinal Surgery, Department of Gastroenterology, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China
1 shared publication
Latest Publications
- 18 December 2018
- Published by Springer Nature in Clinical and Translational Oncology
- Vol. 21 (7) , 924-932
High calpain-1 expression predicts a poor clinical outcome and contributes to tumor progression in pancreatic cancer patients
Pancreatic cancer (PC) is a highly aggressive and metastatic disease, with an elevated mortality rate. It is, therefore, crucial to assess factors affecting the prognosis of PC patients. Meanwhile, calpain-1 is associated with malignant tumor progression and metastasis. Thus, it is meaningful to evaluate the relationship between calpain-1 and PC.
- 18 December 2018
- Published by Springer Nature in Clinical and Translational Oncology
- Vol. 21 (7) , 924-932
High calpain-1 expression predicts a poor clinical outcome and contributes to tumor progression in pancreatic cancer patients
Pancreatic cancer (PC) is a highly aggressive and metastatic disease, with an elevated mortality rate. It is, therefore, crucial to assess factors affecting the prognosis of PC patients. Meanwhile, calpain-1 is associated with malignant tumor progression and metastasis. Thus, it is meaningful to evaluate the relationship between calpain-1 and PC.